Member Info for marik

https://www.google.com/amp/s/amp.theguardian.com/commentisfree/2021/apr/19/lateral-flow-tests-uk-covid

The article i think may have been posted before, but a link within is quite interesting. "Infectious disease modelling shows that if everybody could do a coronavirus test twice a week and self-isolate if positive, the pandemic would collapse."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775777/

"No commercial prospect" - you shouldn't be investing.

>£5

New ii money takes time to formalise and most likely will hit on Monday morning or afternoon. Those already in know will have added large positions if they deem fit and as such the sp will move down to accommodate them. As long as no new news out of the blue, then the sp will stabilise shortly and then start moving up rapidly. However, if an ii sees an opportunity too good to be missed, then the movement could happen today.

GLA

Fantastic reading of the RNS. A strong demand of the Affidx lft test and expecting some big sales these coming weeks. What an amazing job by Alastair has added enormous value to the company within a one year period.

The sp will move rapidly over the next 2 weeks and expecting very good times ahead.

You are right, it should be worth a lot more. But would love to hear your views.

Congratulations to Timster for being the closest. Well done. Three cheers for Timster. Hip Hip...

I'm going for £2.63

What are your guesses?

As it's a bullet point to achievements, its something that has already been done.

250 is from the LinkedIn profile, as mentioned by the poster jdt1990.

GLA

It's mostly pointing to a positive RNS tomorrow morning.

I agree a double up is on the cards.

I agree with PSB:

£5+ with market leading CV

It would be good to get an opinion from those who keep repeating that it's priced in. Priced in how?

What's your thought? Do you think it's priced in?

The value is huge. The initial tests are an absolute must prior to scaling. The final results, in shortly, will only reflect what's already happened on a smaller scale.

The s&s have been exceptional and once scaled up are the route to market. We are well on the way judging from the last few RNS.

GLA

Demand is certainly very big and there is room for many tests. Avacta will likely sell everything out produces. The orders will pile in very quickly.

This seems like a major move by the Gov. I'm expecting other governments to follow suit and potentially go with Avacta.

What I'm guessing is that this BB has too many teenagers and toddlers throwing their toys out of the pram. The AIM market has its ups and downs. It is not a get rich quick gimmick, for that, it's best to look elsewhere. Here you need the stomach for big gains and losses. For those who can't stomach it or don't have a pair, then this isn't for you, perhaps you shouldn't be investing at all or best up place your funds in a simple tracker.